Gary C Doolittle Selected Research

pyrazine-2-diazohydroxide (diazohydroxide)

2/2002

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gary C Doolittle Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 02/2002
3	Melanoma (Melanoma, Malignant) 03/2021 - 02/2002
1	Infections 01/2022
1	Disease Progression 03/2021
1	Neoplasm Metastasis (Metastasis) 03/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2006
1	Adenocarcinoma 11/2006

Drug/Important Bio-Agent (IBA)

2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2021 - 10/2020
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	dabrafenibIBA 10/2020
1	trametinibIBA 10/2020
1	ixabepilone (BMS 247550)FDA Link 11/2006
1	epothilone B (EPO906)IBA 11/2006
1	PyrazinesIBA 02/2002
1	pyrazine-2-diazohydroxide (diazohydroxide)IBA 02/2002
1	DNA (Deoxyribonucleic Acid)IBA 02/2002

Therapy/Procedure

2	Therapeutics 03/2021 - 10/2020
1	Immunotherapy 03/2021
1	Drug Therapy (Chemotherapy) 02/2002